The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder?
Abstract
Now more than ever, let us continue to develop personalized medicine to improve the remission rate for treatment resistant depressed patients. Recent findings about psychomotor retardation-a core symptom of depression-provide new insights into the predictive efficiency of personalized treatments, such as rTMS.
Fichier principal
Deschamps et al (2017)_The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder.pdf (112.06 Ko)
Télécharger le fichier
Origin : Publisher files allowed on an open archive